Marco Daperno

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Alimentary pharmacology & therapeutics

Scandinavian journal of gastroenterology

Diagnostics (Basel, Switzerland)

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Michael V Chiorean, Marco Daperno, Charlie W Lees, Gianluca Bonfanti, Dimitrios Soudis, Irene Modesto, J Jasper Deuring, Roger A Edwards
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program. Advances in therapy (2023)
Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Julian Panes, Axel U Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Silvio Danese
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST. Alimentary pharmacology & therapeutics (2023)
Marco Daperno
Endoscopy in IBD: When and How? Diagnostics (Basel, Switzerland) 13 (22) (2023)
Michela Mangia, Enrica Giuffrida, Valeria Figini, Anna Colombo, Edoardo Carli, Alessandro Lavagna, Marco Mendolaro, Enrico Morello, Maurizio Cosimato, Rodolfo Rocca, Guido Pagana, Marco Daperno
Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform. Scandinavian journal of gastroenterology (2022)
Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Nicolò Mezzina, Fabiana Castiglione, Gionata Fiorino, Lucrezia Laterza, Anna Viola, Lorenzo Bertani, Flavio Caprioli, Maria Cappello, Brigida Barberio, Chiara Ricci, Paola Balestrieri, Marco Daperno, Dario Pluchino, Fernando Rizzello, Maria Lia Scribano, Renato Sablich, Luca Pastorelli, Francesco Manguso, Angela Variola, Antonio Di Sario, Laurino Grossi, Alessandro Armuzzi, null null
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study. Alimentary pharmacology & therapeutics 56 (1) (2022)
Marco Daperno, Cristina Guiotto, Ines Casonato, Guido Pagana, Sergio Micalizzi, Maria C R Azzolina, Claudio Norbiato, Domenico Cosseddu, Rodolfo Rocca, null null
Risk factors of SARS-CoV-2 seroprevalence among hospital employees in Italy: a single-centre study. Internal medicine journal 51 (7) (2021)
Simone Saibeni, Ludovica Scucchi, Gabriele Dragoni, Cristina Bezzio, Agnese Miranda, Davide Giuseppe Ribaldone, Angela Bertani, Fabrizio Bossa, Mariangela Allocca, Andrea Buda, Gianmarco Mocci, Alessandra Soriano, Silvia Mazzuoli, Lorenzo Bertani, Flavia Baccini, Erika Loddo, Antonino Carlo Privitera, Alessandro Sartini, Angelo Viscido, Laurino Grossi, Valentina Casini, Viviana Gerardi, Marta Ascolani, Mirko Di Ruscio, Giovanni Casella, Edoardo Savarino, Davide Stradella, Rossella Pumpo, Claudio Camillo Cortelezzi, Marco Daperno, Valeria Ciardo, Olga Maria Nardone, Flavio Caprioli, Giovanna Vitale, Maria Cappello, Michele Comberlato, Patrizia Alvisi, Stefano Festa, Michele Campigotto, Giorgia Bodini, Paola Balestrieri, Anna Viola, Daniela Pugliese, Alessandro Armuzzi, Massimo C Fantini, Gionata Fiorino, null null
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European gastroenterology journal 8 (10) (2020)

Marco Daperno.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Daperno